nafamostat has been researched along with Autoimmune Thrombocytopenia in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 58-year old woman with idiopathic thrombocytopenic purpura underwent mitral and aortic valve replacements and tricuspid annuloplasty." | 1.31 | Nafamostat mesilate treatment during open heart operation in immune thrombocytopenic purpura. ( Matsuzaki, Y; Nagahama, H; Nakamura, E; Nakamura, K; Onitsuka, T; Yano, M, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakamura, K | 1 |
| Onitsuka, T | 1 |
| Yano, M | 1 |
| Nagahama, H | 1 |
| Nakamura, E | 1 |
| Matsuzaki, Y | 1 |
1 other study available for nafamostat and Autoimmune Thrombocytopenia
| Article | Year |
|---|---|
Nafamostat mesilate treatment during open heart operation in immune thrombocytopenic purpura.
Topics: Anticoagulants; Aortic Valve; Benzamidines; Cardiopulmonary Bypass; Female; Guanidines; Heart Valve | 2000 |